Xianglai Liu

机构：China Pharmaceutical University, Second People Hospital of Hunan, Hainan General Hospital, Hainan Provincial Hospital of Traditional Chinese Medicine, Hunan Institute of Mental Health · ORCID：0000-0001-9613-5628

发表论文 28 篇 · 总被引 203 次 · h-index 9

代表论文

• 2‐Diphenylphosphinoyl ‐acetyl as a Remote Directing Group for the Highly Stereoselective Synthesis of β‐Glycosides (2021 · Chinese Journal of Chemistry · 被引 39)
• Direct Synthesis of 2,6‐Dideoxy‐β‐glycosides and β‐Rhamnosides with a Stereodirecting 2‐(Diphenylphosphinoyl)acetyl Group (2022 · Angewandte Chemie International Edition · 被引 31)
• More than a Leaving Group: N ‐Phenyltrifluoroacetimidate as a Remote Directing Group for Highly α‐Selective 1,2‐ cis Glycosylation (2022 · Angewandte Chemie International Edition · 被引 30)
• Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillance (2023 · BMC Psychiatry · 被引 16)
• Integrated untargeted fecal metabolomics and gut microbiota strategy for screening potential biomarkers associated with schizophrenia (2022 · Journal of Psychiatric Research · 被引 16)
• Glycosylation of a Ketone with an O-Glycosyl Trichloroacetimidate Provides an Enol Glycoside (2018 · Organic Letters · 被引 13)